GLENMARK PHARMACEUTICALS LTD. - Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials
03 Jul 2014
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 03, 2014, titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"
Source:
BSE India